###begin article-title 0
A screen for proteins that interact with PAX6: C-terminal mutations disrupt interaction with HOMER3, DNCL1 and TRIM11
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
The PAX6 protein is a transcriptional regulator with a key role in ocular and neurological development. Individuals with heterozygous loss-of-function mutations in the PAX6 gene have malformations of the eye and brain. Little is known about the interactions of PAX6 with other proteins, so we carried out a systematic screen for proteins that interact with PAX6.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
###xml 116 121 <span type="species:ncbi:4932">Yeast</span>
###xml 541 549 <span type="species:ncbi:9606">patients</span>
We used bioinformatics techniques to characterise a highly conserved peptide at the C-terminus of the PAX6 protein. Yeast two-hybrid library screens were then carried out to identify brain-expressed proteins that interact with the C-terminal peptide and with the entire PAX6 proline-serine-threonine-rich domain. Three novel PAX6-interacting proteins were identified: the post-synaptic density (PSD) protein HOMER3, the dynein subunit DNCL1, and the tripartite motif protein TRIM11. Three C-terminal PAX6 mutations, previously identified in patients with eye malformations, all reduced or abolished the interactions.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
###xml 287 295 <span type="species:ncbi:9606">patients</span>
Our preliminary data suggest that PAX6 interacts with HOMER3, DNCL1 and TRIM11. We propose that the interaction of PAX6 with HOMER3 and DNCL1 is a mechanism by which synaptic activation could lead to changes in neuronal transcriptional activity, and that some of the neural anomalies in patients with PAX6 mutations could be explained by impaired protein-protein interactions.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 41 43 41 43 <underline xmlns:xlink="http://www.w3.org/1999/xlink">pa</underline>
###xml 50 51 50 51 <underline xmlns:xlink="http://www.w3.org/1999/xlink">x</underline>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6</italic>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 608 609 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 759 760 759 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 880 881 880 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 432 435 <span type="species:ncbi:9606">man</span>
###xml 440 445 <span type="species:ncbi:10090">mouse</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10116">rats</span>
The PAX6 protein is a member of the PAX (paired-box) family of transcriptional regulators and is essential for normal ocular and neural development [1]. Heterozygous mutations of the human PAX6 gene cause aniridia (absence of the iris) and a range of other congenital eye malformations [2]. Neural defects such as foveal hypoplasia and optic nerve hypoplasia are common in PAX6-associated eye disease [3-5]. Homozygous mutations in man and mouse are lethal and result in severe developmental abnormalities including anophthalmia, severe reduction of the olfactory structures and gross brain malformations [2,6]. The roles of PAX6 in brain development have mainly been studied in homozygous mutant mice or rats and include arealisation of the cerebral cortex [7], formation of the prosencephalon-mesencephalon boundary [8], axon guidance [8], differentiation of neurons from glia [9] and neuronal migration in the cerebellum [10].
###end p 9
###begin p 10
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
The discovery of multiple and diverse roles for PAX6 in brain development prompted MRI analyses of aniridia patients, and a range of distinctive brain anomalies were uncovered. The most common and striking of these was absence or hypoplasia of the anterior commissure [11]. Other defects included absence or hypoplasia of the pineal gland, cortical polymicrogyria, white matter changes in the corpus callosum and grey matter changes in the cerebellum [11-13]. Functional changes included hyposmia and abnormal inter-hemispheric auditory transfer [11,14].
###end p 10
###begin p 11
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax2 </italic>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ngn2 </italic>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 550 559 550 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glucagon </italic>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
The defining feature of all PAX proteins is the presence of a 128 amino acid DNA-binding paired domain that has been highly conserved over evolution [1]. In addition to the paired domain, PAX6 also contains a DNA-binding homeodomain and a proline, serine and threonine-rich (PST) domain at the C-terminus [1,6]. The PST domain, which encompasses the C-terminal 145 amino acids of PAX6, has been shown to act as a transcriptional activator [6]. The PAX6 protein directly regulates a wide range of target genes [1,2] including Pax2 [15], Ngn2 [16] and glucagon [17].
###end p 11
###begin p 12
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 544 545 544 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 731 736 731 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ngn2 </italic>
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mash1</italic>
###xml 916 921 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
The Pax6 gene has a spatially and temporally complex expression pattern in the eye, brain, nasal structures, spinal cord and pancreas [1]. Although PAX6 is clearly involved in multiple developmental processes, common themes are now emerging concerning the role of PAX6 in neural tissues. Gradients of Pax6 expression are important for determining positional characteristics in the retina [18] and the neocortex [7]. PAX6 plays a role in development of specific axonal connections between the retina and the brain [18] and within the forebrain [8,19]. It is also involved in the differentiation of neural cell types from multipotent precursors in the retina [16] and the cerebral cortex [9] through activation of bHLH genes such as Ngn2 and Mash1. These studies provide a clear link between PAX6 function in the retina and the brain, and are of particular relevance to the neurological phenotypes of individuals with PAX6 mutations.
###end p 12
###begin p 13
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 409 420 405 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">crystallin </italic>
###xml 426 428 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 503 505 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 537 546 533 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">glucagon </italic>
###xml 623 625 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
It is becoming apparent that transcription factors do not act in isolation but are dependent on interactions with other proteins to carry out their function [20,21]. These interactions introduce more specificity into the regulatory function of a given transcription factor. To date only three PAX6 protein-protein interactions have been described: with SOX2 on the lens-specific enhancer element of the delta-crystallin gene [22]; with MDIA, which modulates PAX6 activity in early neuronal development [23], and with MAF proteins on the glucagon promoter, which causes increased expression of this pancreatic hormone gene [17].
###end p 13
###begin p 14
###xml 335 340 <span type="species:ncbi:4932">yeast</span>
Here we report the preliminary results of the first systematic screen for proteins that interact with PAX6. We used sequence alignment algorithms and secondary structure prediction programs to define a new domain of 32 amino acids at the C-terminal end of the PAX6 protein. We then screened a brain library with this peptide using the yeast two-hybrid technique and identified three novel interacting proteins, HOMER3, DNCL1 and TRIM11. The interaction between PAX6 and these proteins was disrupted by naturally occurring C-terminal PAX6 mutations.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
A highly conserved C-terminal PAX6 peptide
###end title 16
###begin p 17
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 18 20 18 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 382 401 382 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ambystoma mexicanum</italic>
###xml 419 440 419 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Paracentrotus lividus</italic>
###xml 450 452 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 373 380 <span type="species:ncbi:8296">axolotl</span>
###xml 382 401 <span type="species:ncbi:8296">Ambystoma mexicanum</span>
###xml 419 440 <span type="species:ncbi:7656">Paracentrotus lividus</span>
We and others [31-33] noted that there is significant sequence conservation at the C-terminal end of the PAX6 protein. BLAST analysis of the amino acid sequence of the PAX6 PST domain (aa 278-422) revealed a highly conserved motif within the last 28 amino acids (beginning at the 'GLISP' motif, Figure 1a). Strong conservation was seen in distantly related species such as axolotl (Ambystoma mexicanum) and sea urchin (Paracentrotus lividus) (Figure 1a).
###end p 17
###begin p 18
Characterisation of the PAX6 C-terminal peptide. (a) CLUSTAL alignment of the terminal 42 amino acids of PAX6 from diverse species. (*) indicates invariant residues, (:) indicates highly similar substitutions and (.) indicates moderately similar substitutions. (b) Secondary structure analysis of the highly conserved terminal 28 amino acids predicts a single beta sheet (arrow) in the SVPVQ peptide. (c) When 4 residues are added in the N-terminal direction, 2 beta sheets are now predicted.
###end p 18
###begin p 19
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 1287 1289 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
We subjected the whole PAX6 PST domain to secondary structure analysis using JPRED, a program that uses a number of different protein structure prediction algorithms to generate a consensus secondary structure (Figure 1) [25,26]. The PST domain was largely devoid of predicted secondary structure except for the C-terminal region, which contained two predicted beta sheets within the highly conserved domain, one in the 'GLISP' motif and one in the 'SPVPQ' motif (identical to the pattern shown in Figure 1c). Initially we defined the C-terminal domain as running from the 'GLISP' motif up to the stop codon, since this region was most highly conserved and contained strongly predicted secondary structure elements. However when we performed secondary structure prediction analysis on this 28 amino acid peptide, the first beta sheet was lost (Figure 1b). Addition of another 4 amino acids (TTST) immediately before 'GLISP' caused recovery of the first beta sheet (Figure 1c). Although these 4 residues are not highly conserved (Figure 1a), they appear to be important for seeding the first beta sheet and therefore for secondary structure. Thus we define the C-terminal peptide as being the final 32 amino acids of PAX6, running from threonine 391 to the stop codon (top line of Figure 1c).
###end p 19
###begin title 20
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid screening
###end title 20
###begin p 21
###xml 152 157 <span type="species:ncbi:4932">yeast</span>
###xml 266 271 <span type="species:ncbi:4932">yeast</span>
###xml 318 323 <span type="species:ncbi:10090">mouse</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
###xml 461 464 <span type="species:ncbi:9606">man</span>
###xml 469 474 <span type="species:ncbi:10090">mouse</span>
###xml 495 500 <span type="species:ncbi:10090">mouse</span>
We hypothesised that the C-terminal peptide might be involved in protein-protein interactions, and we tested this by screening a cDNA library using the yeast two-hybrid system with a construct (PAX6CTP) in which the 32 amino acid C-terminal peptide was fused to the yeast GAL4 DNA binding domain. We chose to screen a mouse brain cDNA library as no human libraries were available. Given the fact that the amino acid sequence of the PAX6 protein is identical in man and mouse, we reasoned that a mouse brain library would yield relevant interactors. For comparison we also carried out the screen using a construct containing the whole PST domain (PAX6PST).
###end p 21
###begin p 22
###xml 251 258 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1 </italic>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pin </italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlc8</italic>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1 </italic>
###xml 506 513 506 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 525 531 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1 </italic>
###xml 546 553 546 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
The C-terminal peptide screen gave 15 colonies that were positive with all three reporters and the PST domain screen gave 62 colonies. The interacting plasmids were isolated and the cDNA inserts sequenced. Three cDNAs were identified 3 or more times, Homer3 (NM_011984), Dncl1 (Dynein cytoplasmic light chain 1, NM_019682, also known as Pin or Dlc8) and Trim11 (Tripartite motif protein family member 11, NM_053168). Homer3 (6 clones) and Dncl1 (2 clones) were identified in the C-terminal peptide screen. Homer3 (7 clones), Dncl1 (2 clones) and Trim11 (6 clones) were identified in the PST domain screen. All cDNA inserts were in-frame with the coding region of the pPC86 GAL4 activation domain. None of the cDNAs was present in a list of known false positives [34].
###end p 22
###begin p 23
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
HOMER3 is a member of the HOMER family of neuronal post-synaptic density (PSD) proteins [35]. DNCL1 is a subunit of two motor protein complexes, dynein and myosin-Va, both of which are involved in intracellular trafficking of proteins and organelles in neurons [36,37]. TRIM11 is a member of the tripartite motif protein family and contains a RING finger, a B-box zinc finger, a coiled coil domain and a B30.2 domain [38]. The possible significance of the interactions between these proteins and PAX6 is discussed below.
###end p 23
###begin title 24
Semi-quantitative PCR
###end title 24
###begin p 25
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3</italic>
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1 </italic>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3</italic>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1</italic>
###xml 238 245 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atp5a1</italic>
###xml 277 283 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 287 294 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atp5a1 </italic>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 388 394 388 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1</italic>
###xml 403 410 403 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 546 552 546 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 593 600 593 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atp5a1 </italic>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
To check that the Homer3, Dncl1 and Trim11 clones were not identified multiple times solely because they are highly abundant in the library, we performed a semi-quantitative PCR assay. We compared the relative abundance of Homer3, Dncl1, Trim11 and Pax6 with Gapdh and Atp5a1. Gapdh and Atp5a1 both show strong constitutive expression in a variety of tissues including the brain [29,30]. Homer3, Dncl1, Trim11 and Pax6 were only amplified strongly after 35 cycles of PCR (Figure 2) and were therefore present at relatively low levels compared to Gapdh (amplified strongly after 25 cycles) and Atp5a1 (amplified strongly after 30 cycles; Figure 2).
###end p 25
###begin p 26
###xml 34 56 34 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3, Dncl1, Trim11 </italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 188 194 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1 </italic>
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atp5a1 </italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 382 385 380 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hae</italic>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Semi-quantitative PCR analysis of Homer3, Dncl1, Trim11 and Pax6 in the mouse brain cDNA library. Library cDNA was amplified with primers specific for Pax6 (600 bp), Homer3 (485 bp band), Dncl1 (485 bp) and Trim11 (609 bp) for 20, 25, 30 or 35 cycles. Atp5a1 (415 bp) and Gapdh (450 bp), which are highly expressed in the brain, are included for comparison. M indicates the Phix174 HaeIII DNA size marker; the positions of the 603 bp and 310 bp marker bands are indicated.
###end p 26
###begin p 27
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3</italic>
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1 </italic>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
We concluded that Homer3, Dncl1 and Trim11 clones were not highly abundant in the library. This is consistent with the idea that they were pulled out because the encoded proteins interact specifically with the C-terminal peptide or PST domain of PAX6.
###end p 27
###begin title 28
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid pairwise interactions
###end title 28
###begin p 29
###xml 559 565 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1 </italic>
###xml 569 576 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 645 652 645 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 754 761 754 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 903 910 903 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
By library screening we identified two proteins (HOMER3 and DNCL1) that interact with the C-terminal peptide and three proteins (HOMER3, DNCL1 and TRIM11) that interact with the whole PST domain. This suggests that HOMER3 and DNCL1 interact specifically with the C-terminal peptide while TRIM11 interacts with a more N-terminal part of the PST domain. We conducted pairwise tests between specific constructs to confirm the interactions identified in the library screen and to further investigate the interaction between PAX6 and HOMER3, DNCL1 and TRIM11. The Dncl1 and Trim11 clones that were pulled out of the library were full-length, but the Homer3 cDNAs lacked the N-terminal 70 amino acids. The missing coding region was inserted into the truncated Homer3 cDNA to give a full-length expression construct (see Methods). Pairwise interactions were carried out with both the full-length and truncated Homer3 clones.
###end p 29
###begin p 30
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 </italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3 </italic>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 934 935 934 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 943 944 943 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1014 1015 1014 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1023 1024 1023 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
We confirmed that the whole PAX6 PST domain interacts with HOMER3 (full-length and truncated constructs), TRIM11 and DNCL1, as all three reporter genes were strongly activated in pairwise tests (Figure 3; Table 1). In contrast the interaction between the C-terminal peptide and HOMER3 or DNCL1 could not be confirmed with pairwise tests (Table 1). Occasionally, partial suppression of growth on plates containing 5-fluoro-orotic acid was observed, indicating low-level activation of the URA3 reporter; however HIS3 and LacZ activation were not observed. The reasons for this are not clear, although it may be that the pairwise tests were of sub-optimal sensitivity compared to the library screen. However we were able to confirm that the C-terminal peptide is important for the interaction with HOMER3 and DNCL1 because interaction with the PAX6PST-CT construct, which lacks the final 32 amino acids, was completely abolished (Figure 3, Table 1). TRIM11 interacted equally well with PAX6PST and PAX6PST-CT (Figure 3, Table 1). This is consistent with the library screens in which TRIM11 was isolated with the PST domain but not with the C-terminal peptide and supports the idea that the C-terminal peptide is not important for the interaction between PAX6 and TRIM11.
###end p 30
###begin p 31
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
LacZ reporter gene activation in pairwise tests. pPC86 constructs are shown across the top, and pDBLeu constructs are shown down the right hand side. PAX6PST, PAX6 PST domain; PAX6PST/Q422R, PAX6 PST domain with the Q422R mutation; PAX6PST/X423L, PAX6 PST domain with the X423L mutation, PAX6PST/1615del10, PAX6 PST domain with the 1615 del10 mutation; PAX6PST-CT, PAX6 PST domain minus the C-terminal peptide. 'Truncated HOMER3' is HOMER3 lacking the N-terminal 70 amino acids. Five control strains are shown for comparison (left). These range from non-interactor (A) to strong interactor (E).
###end p 31
###begin p 32
Pairwise interaction tests between normal and mutant PAX6 constructs and HOMER3, DNCL1 and TRIM11. +++: strong interaction; ++: moderate interaction; +: weak interaction; (+) borderline interaction with one or two reporters activated at very low levels; 0: no interaction. PAX6PST, PAX6 PST domain; PAX6CTP, PAX6 C-terminal peptide; PAX6PST-CT, PAX6 PST domain minus the C-terminal peptide; PAX6PST/Q422R, PAX6 PST domain with the Q422R mutation; PAX6PST/X423L, PAX6 PST domain with the X423L mutation, PAX6PST/1615del, PAX6 PST domain with the 1615 del10 mutation. HOMER3-FL, HOMER3 full-length clone; HOMER3-Tr, truncated HOMER3 clone lacking the N-terminal 70 amino acids.
###end p 32
###begin p 33
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
###xml 450 458 <span type="species:ncbi:9606">patients</span>
Having confirmed that HOMER3, DNCL1 and TRIM11 interact with the PAX6 PST domain, we next investigated how the interactions were affected by three C-terminal PAX6 mutations that have been previously described in patients with ocular anomalies. The first mutation is a single nucleotide substitution 1627A>G that causes a glutamine to arginine amino acid substitution in the last codon of PAX6. This missense mutation (Q422R) has been reported in two patients, one affected by anterior segment dysgenesis with uveal ectropion and one with typical aniridia and foveal hypoplasia [27,33].
###end p 33
###begin p 34
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
The second mutation (1615del10) was found in an aniridia family [28]. This frame-shifting deletion occurs just before the PAX6 stop codon and is predicted to cause translational read-through into the 3' untranslated region, generating a protein in which the last 5 amino acids of the C-terminal peptide are replaced by a 103 amino acid-extension. Affected individuals in this family showed unusual neurobehavioural traits including impaired social cognition and poor verbal inhibition [28]. MRI analysis revealed grey matter abnormalities in the frontal lobe, temporal lobe and cerebellum, and white matter deficits in the corpus callosum [13].
###end p 34
###begin p 35
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
The third mutation 1629insT (X423L) has been reported in several aniridia patients [11,12,27,33]. Insertion of a single T nucleotide at position 1629 changes the stop codon (TAA) to a leucine codon (TTA) and generates a full length PAX6 protein with a C-terminal extension that extends for a further 35 amino acids into the 3' untranslated region. MRI analysis of six patients with this mutation revealed variable brain defects including absence or hypoplasia of the anterior commissure, pineal gland and olfactory bulbs [12]. Two patients had temporal polymicrogyria, one in association with epilepsy [12].
###end p 35
###begin p 36
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The three mutations were introduced into the PAX6PST construct, and pairwise tests were carried out to investigate the interaction of each mutant protein with HOMER3, DNCL1 and TRIM11. All three mutations had a clear effect on the interactions. The most subtle mutation (Q422R) caused a reduction in the interaction with HOMER3 and DNCL1 (Figure 3, Table 1). The C-terminal extension mutations X423L and1615del10 mutations both dramatically reduced or abolished the interaction with HOMER3 and DNCL1 (Figure 3, Table 1).
###end p 36
###begin p 37
None of the three mutations affected the interaction with TRIM11 which again is consistent with the hypothesis that TRIM11 interacts with a more N-terminal part of the PST domain.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 184 189 <span type="species:ncbi:4932">yeast</span>
On the basis of secondary structure predictions and amino acid sequence conservation, we defined a novel PAX6 protein domain, which we have called the C-terminal peptide. We performed yeast two-hybrid library screens with the C-terminal peptide and the whole PST domain and we identified three novel interacting proteins, HOMER3, DNCL1 and TRIM11. In library screens, HOMER3 and DNCL1 interacted with the C-terminal peptide and the PST domain while TRIM11 interacted only with the PST domain, suggesting that HOMER3 and DNCL1 specifically interact with the C-terminal peptide while TRIM11 interacts with a more N-terminal part of the PST domain. The interactions between the PST domain and HOMER3, DNCL1 and TRIM11 were confirmed in pairwise tests. We were not able to confirm the interaction between HOMER3 or DNCL1 with the C-terminal peptide construct in pairwise tests, but we showed that the C-terminal peptide was important for PAX6/HOMER3 or PAX6/DNCL1 interaction because HOMER3 and DNCL1 did not interact with a PST domain construct lacking the C-terminal peptide.
###end p 39
###begin p 40
###xml 170 173 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
HOMER3 is found in the PSD of neurons and directly binds to type I metabotropic glutamate receptors, which act via phospholipase C to stimulate IP3-mediated release of Ca2+ from intracellular vesicles [35,39]. HOMER3 is a member of the HOMER family of proteins that are constitutively expressed in the brain and play a role in post-synaptic signalling and receptor trafficking by forming multivalent links with various receptors and PSD scaffolding proteins [35,39-41]. HOMER proteins have also been implicated in axon guidance during brain development [42].
###end p 40
###begin p 41
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
DNCL1 is a subunit of two intracellular transport protein complexes, dynein and myosin Va [36]. Dynein and myosin Va are involved in the microtubule-based and actin-based movement respectively of proteins, organelles and vesicles in neurons [36,37]. Myosin Va is enriched in the PSD [43], and DNCL1 binds to a variety of PSD proteins including guanylate kinase domain-associated protein [44] and neuronal nitric oxide synthase [45].
###end p 41
###begin p 42
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
TRIM11 is a member of the mouse tripartite motif protein family (also known as the RBCC family), and contains the three characteristic structural motifs of this protein family, a RING finger, a B-box zinc finger, and a coiled coil domain, as well as a B30.2 domain that is found in many but not all TRIM proteins [38]. TRIM11 interacts with Humanin, a protein that suppresses the neurotoxicity associated with Alzheimer's disease [46]. TRIM11 lowers Humanin levels by a mechanism that appears to involve ubiqutin-mediated proteasomal degradation [46].
###end p 42
###begin p 43
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
At present our data must be considered preliminary because the interactions have not been confirmed by any other approach. However it is interesting to speculate that the interaction of PAX6 with HOMER3 and DNCL1 may be the basis of a mechanism by which synaptic signalling causes changes in gene expression. We propose that PAX6 is sequestered in the PSD by binding to HOMER3. Since receptor activation causes dissociation of HOMER proteins [35], PAX6 may be released as a result of synaptic activity, allowing it to interact with DNCL1. The PAX6/DNCL1 complex could then participate in myosin Va-mediated transport along the PSD-associated actin cytoskeleton followed by dynein-mediated transport along the microtubule network, eventually reaching the nucleus [36]. Since TRIM11 is implicated in protein degradation [46], it may play a role in PAX6 protein turnover.
###end p 43
###begin p 44
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 266 271 <span type="species:ncbi:10090">mouse</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
Precedents for association of transcription factors with the post-synaptic density include STAT3 and CREB, which act as messengers between the synapse and the nucleus [47,48]. Although the full-length PAX6 protein is predominantly nuclear, there is good evidence in mouse, quail and nematode for an isoform that lacks the paired domain, is both nuclear and cytoplasmic, and binds DNA through the homeodomain alone [49-51]. In mice the paired-less isoform is relatively abundant in brain [49]; however its subcellular localisation in neurones, and the possibility of an association with the PSD, remains to be investigated.
###end p 44
###begin p 45
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 786 787 786 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6</italic>
###xml 832 838 832 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HOMER3</italic>
###xml 840 846 840 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DNCL1 </italic>
###xml 850 857 850 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRIM11 </italic>
###xml 870 875 <span type="species:ncbi:9606">human</span>
Regarding the subcellular localisation of the putative interacting proteins, HOMER3 is predominantly found at the interface between the PSD and the cytoplasm [39], DNCL1 is chiefly cytoplasmic, although nuclear localisation has been reported [51], and TRIM11 is both nuclear and cytoplasmic [38]. Therefore cytoplasmic PAX6 could potentially interact with all three proteins, while nuclear PAX6 could interact with TRIM11 and DNCL1. At the tissue level, HOMER3 expression has been detected in thymus and lung but it has mainly been studied in brain where it is found in the forebrain, hippocampus and cerebellum [39]. DNCL1 and TRIM11 both have wide expression domains that include the brain [44,38]. Thus the expression of all three interactors overlaps with PAX6 at the tissue level [2,7,8,10]. We detected co-expression of PAX6, HOMER3, DNCL1 and TRIM11 by RT-PCR in human adult brain RNA (IH, L Harrison and A Brown, data not shown).
###end p 45
###begin p 46
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
We demonstrated that the interaction between the PST domain and HOMER3 or DNCL1 was impaired by three naturally occurring mutations that are located in the PAX6 C-terminal peptide. The Q422R mutation, which involves a glutamine to arginine substitution at the last amino acid position of PAX6, caused a reduction in the interaction with HOMER3 and DNCL1. The X423L and 1615del10 mutations severely reduced or completely abolished the interaction with HOMER3 and DNCL1. The predicted effect of the X423L and 1615del10 mutations is to cause translation into the 3' untranslated region, thus generating proteins with abnormal extensions that might be expected to disrupt the conformation of the C-terminal end of the protein. The 1615del10 mutation also removes the last 5 amino acids of the C-terminal peptide [28].
###end p 46
###begin p 47
None of the mutations affected the interaction with TRIM11, suggesting that they do not alter the conformation of the more N-terminal part of the PST domain. All our data are consistent with the hypothesis that TRIM11 does not interact with the C-terminal peptide, but interacts with the PST domain between the homeodomain and the C-terminal peptide.
###end p 47
###begin p 48
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 924 929 924 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
###xml 940 942 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
Most aniridia patients are heterozygous for mutations that introduce a premature termination codon into the PAX6 open reading frame [2,52]. These alleles would be expected to encode truncated proteins or no protein at all if the mutant RNA is degraded by nonsense-mediated decay [52]. We propose that the brain anomalies that have been observed in aniridia patients may be partly explained by impaired interaction between PAX6 and HOMER3, DNCL1 and TRIM11. The neurobehavioural phenotype associated with 1615del10 and the polymicrogyria associated with X423L may result from a specific effect of these unusual C-terminal extension mutations. There is evidence that signalling and transport mechanisms that were initially characterized in the brain may also be conserved in the retina, suggesting that impaired PAX6 protein-protein interactions may also have implications for the retinal defects observed in individuals with PAX6 mutations [53,54].
###end p 48
###begin title 49
Conclusion
###end title 49
###begin p 50
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAX6 </italic>
###xml 361 369 <span type="species:ncbi:9606">patients</span>
We have presented preliminary evidence that the neurodevelopmental transcriptional regulator PAX6 interacts with HOMER3, DNCL1 and TRIM11. We suggest that the interaction of PAX6 with HOMER3 and DNCL1 is a mechanism by which synaptic signalling could lead to regulated changes in gene expression in neurons. We also propose that some of the neural anomalies in patients with PAX6 mutations may be explained by impaired protein-protein interactions.
###end p 50
###begin title 51
Methods
###end title 51
###begin title 52
Bioinformatics techniques
###end title 52
###begin p 53
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 245 250 <span type="species:ncbi:9606">human</span>
Sequence database searches were carried out using the BLAST program available through the Bioinformatics Applications at the Rosalind Franklin Centre for Genomics Research [24]. Protein sequences that were highly homologous to the C-terminus of human PAX6 were aligned using CLUSTAL [24]. Secondary structure prediction was performed using the JPRED consensus method [25,26].
###end p 53
###begin title 54
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid constructs
###end title 54
###begin p 55
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 906 909 906 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 915 918 915 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 117 122 <span type="species:ncbi:9606">Human</span>
###xml 365 370 <span type="species:ncbi:4932">yeast</span>
All cDNA and amino acid numbering is based on the human PAX6 cDNA and protein reference sequences available from the Human PAX6 Allelic Variant Database web site [27]. Standard PCR and subcloning techniques were used to make three PAX6 cDNA constructs in the pDBLeu expression vector (ProQuest Two-Hybrid System, Invitrogen), which generates a protein fused to the yeast GAL4 DNA binding domain. PAX6PST contains the whole PST domain (amino acids 278-422 of the full-length PAX6 protein). Primers were ST001 (forward) 5'-AAA AGT TCG ACT GCC AGC AAC ACA CCT AGT C-3' and ST005 (R) 5'-TTT TGC GGC TTT TTA CTG TAA TCT TGG CCA GTA TTG-3'. PAX6CTP contains the newly defined C-terminal peptide alone (391-422). Primers were ST004 (F) 5'-AAA AGT CGA CTA CCA CTT CAA CAG GAC TCA TT-3' and ST005 (R). PAX6PST-CT contains the PST domain minus the C-terminal peptide (278-390). This was made by cutting PAX6PST with NdeI and NotI to drop out the C-terminal peptide, and inserting a synthetic linker between the two restriction sites. All fragments generated by PCR or with linkers were sequenced to check that no errors had been introduced.
###end p 55
###begin p 56
###xml 191 192 191 192 <underline xmlns:xlink="http://www.w3.org/1999/xlink">C</underline>
A PAX6 PST domain construct containing the mutation 1627A>G (Q422R) was generated in the same way as the PAX6PST construct, but using the reverse PCR primer ST006 5'-TTT TGC GGC CGC TTT TTA CCG TAA TCT TGG CCA GTA TTG AG-3', which contains the mutant nucleotide substitution (underlined).
###end p 56
###begin p 57
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
cDNA sequences containing the mutations 1615del10 [28] and 1629insT (X423L) [12] were generated by PCR from reverse transcribed RNA (a gift from Dr K Williamson and Prof V van Heyningen). Primers were ST015 (F) 5'-CCC ACA TAT GCA GAC ACA C-3' and ST031 (R) 5'-TTG CGG CCG CAT CCA TCC AGT CTA CAT TGT TC-3'. The PAX6PST construct was cut with NdeI and NotI to release the normal C-terminal peptide, and the mutant sequence was inserted.
###end p 57
###begin title 58
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid library screens
###end title 58
###begin p 59
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3</italic>
###xml 286 291 286 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 </italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3 </italic>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 </italic>
###xml 692 697 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 </italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
###xml 197 202 <span type="species:ncbi:4932">yeast</span>
###xml 893 898 <span type="species:ncbi:4932">yeast</span>
A mouse brain cDNA library (ProQuest, Invitrogen) was screened with the PAX6PST and PAX6CTP pDBLeu constructs. The library was constructed in the pPC86 vector, which produces proteins fused to the yeast GAL4 activation domain. The system uses three GAL4-activated reporter genes, HIS3, URA3 and lacZ, to identify positive interactions. Reporters are activated when the bait protein fused to the GAL4 DNA binding domain (pDBLeu) interacts with the prey protein fused to the GAL4 activation domain (pPC86), thus reconstituting GAL4 function. HIS3 activation allows growth on plates lacking histidine. Weak URA3 activation suppresses growth on plates containing 5-fluro-orotic acid while strong URA3 activation permits growth on plates lacking uracil. LacZ activation causes X-gal to turn blue in a beta-galactosidase assay. All assays were carried out in parallel with the five ProQuest control yeast strains A-E, which range from non-interactor (A) to strong interactor (E).
###end p 59
###begin p 60
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3 </italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3 </italic>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 108 113 <span type="species:ncbi:4932">yeast</span>
All procedures were carried out according to the supplier's protocols. Briefly, chemically competent MaV203 yeast cells were co-transformed with the cDNA library and the bait plasmid pDBLeu PAX6CTP or pDBLeu PAX6PST. Transformants (5 x 107) were plated on medium lacking histidine to check for HIS3 activation. HIS3 positives were then assayed for all 3 reporters. The pPC86 prey plasmid was isolated from all HIS3/URA3/LacZ positives and the cDNA insert sequenced. BLAST searches were performed to identify the cDNA insert [24].
###end p 60
###begin title 61
Pairwise interactions
###end title 61
###begin p 62
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIS3</italic>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3 </italic>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
Specific interactions were tested by transforming competent MaV203 yeast cells with one bait construct (in pDBLeu) and one prey construct (in pPC86) and testing the resulting colonies for activation of the HIS3, URA3 and LacZ reporters as before.
###end p 62
###begin p 63
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
To create a full-length Homer3 clone for pairwise tests, a cDNA clone (IMAGE clone 3602414, accession number BE569374) containing the missing N-terminal 70 amino acids was identified by a BLAST search of the EST nucleotide sequence database and obtained from the Rosalind Franklin Centre for Genomics Research. The missing fragment was amplified from the IMAGE clone by PCR and inserted into the pPC86-Homer3 plasmid to create a full-length expression construct.
###end p 63
###begin title 64
Semi-quantitative PCR
###end title 64
###begin p 65
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6</italic>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dncl1</italic>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim11 </italic>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Atp5a1 </italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 881 882 881 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1170 1173 1137 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hae</italic>
To check the relative representation of clones in the cDNA library, semi-quantitative PCR was performed on Pax6, Homer3, Dncl1, Trim11 and the constitutively expressed genes Gapdh and Atp5a1 [29,30]. Primers were designed to cross at least one intron, so that only correctly spliced clones were amplified. Primer sequences were: Pax6-F CAG CCA AAA TAG ATC TAC CTG; Pax6-R CGA TCA CAT GCT CTC TCC TT; Homer3-F CCC AGG TGG CTG TAG AGC; Homer3-R CTC TAC ACA GTG CAA AGC TCA G; Trim11-F GTG CAG GAT GTG AAG CTG; Trim11-R GCC TGC AGA TAG TCA TAG GG; Dncl1-F CAA AAA TGC AGA CAT GTC G; Dncl1-R CTA AGG GAG AAA AAA ATG GGG; Gapdh-F: CAT CAC CAT CTT CCA GGA GC; Gapdh-R: ATG ACC TTG CCC ACA GCC TT; Atp5a1-F: CAC ACG TGA GAT GTC CTC CA; Atp5a1-R: CAC AGA GAT TCG GGG ATA A. 10 ng library cDNA were amplified in a reaction containing 1xAmpliTaq polymerase buffer (Perkin Elmer), 1.5 mM MgCl2, 200muM each primer and 2.5 units of AmpliTaq polymerase (Perkin Elmer). PCR conditions were (95degreesC for 30 sec) x 1, (94degreesC for 30 sec, 55degreesC for 30 sec, 72degreesC for 30 sec) x 32 and (72degreesC for 2 min) x 1. Products were resolved on a 2.5% agarose gel with PhiX174/HaeIII size markers (Promega).
###end p 65
###begin title 66
Abbreviations
###end title 66
###begin p 67
PST domain, proline-, serine- and threonine-rich domain; PSD, post-synaptic density; PCR, polymerase chain reaction.
###end p 67
###begin title 68
Authors' contributions
###end title 68
###begin p 69
STC carried out the bioinformatic analyses and all experimental work. IMH conceived, designed and supervised the study, and obtained funding. The manuscript was prepared jointly by STC and IMH, who have both read and approved the final version.
###end p 69
###begin title 70
Acknowledgements
###end title 70
###begin p 71
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homer3 </italic>
###xml 65 70 <span type="species:ncbi:4932">yeast</span>
We gratefully acknowledge Dr A Brown for technical advice on the yeast two-hybrid system and the Rosalind Franklin Centre for Genomics Research for supplying the Homer3 IMAGE clone. STC was supported by Fight for Sight and IMH was supported by a Career Development Award from the UK Medical Research Council.
###end p 71
###begin article-title 72
Pax6, a pleiotropic player in development
###end article-title 72
###begin article-title 73
PAX6 in sensory development
###end article-title 73
###begin article-title 74
Aniridia. A review
###end article-title 74
###begin article-title 75
PAX6 missense mutation in isolated foveal hypoplasia
###end article-title 75
###begin article-title 76
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations
###end article-title 76
###begin article-title 77
PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects
###end article-title 77
###begin article-title 78
Distinct actions of Emx1, Emx2, and Pax6 in regulating the specification of areas in the developing neocortex
###end article-title 78
###begin article-title 79
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Pax-6 functions in boundary formation and axon guidance in the embryonic mouse forebrain
###end article-title 79
###begin article-title 80
Glial cells generate neurons: the role of the transcription factor Pax6
###end article-title 80
###begin article-title 81
Role of Pax6 in development of the cerebellar system
###end article-title 81
###begin article-title 82
###xml 82 88 <span type="species:ncbi:9606">humans</span>
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans
###end article-title 82
###begin article-title 83
Polymicrogyria and absence of pineal gland due to PAX6 mutation
###end article-title 83
###begin article-title 84
###xml 92 97 <span type="species:ncbi:9606">human</span>
Heterozygous PAX6 mutation, adult brain structure and fronto-striato-thalamic function in a human family
###end article-title 84
###begin article-title 85
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Deficient auditory interhemispheric transfer in patients with PAX6 mutations
###end article-title 85
###begin article-title 86
Spatial specification of mammalian eye territories by reciprocal transcriptional repression of Pax2 and Pax6
###end article-title 86
###begin article-title 87
Pax6 is required for the multipotent state of retinal progenitor cells
###end article-title 87
###begin article-title 88
Interaction of Maf transcription factors with Pax-6 results in synergistic activation of the glucagon promoter
###end article-title 88
###begin article-title 89
Pax6 is required for establishing the naso-temporal and dorsal characteristics of the optic vesicle
###end article-title 89
###begin article-title 90
Pax6 is required for the normal development of the forebrain axonal connections
###end article-title 90
###begin article-title 91
Molecular biology of the Ets family of transcription factors
###end article-title 91
###begin article-title 92
The cellular Pax-Hox-helix connection
###end article-title 92
###begin article-title 93
Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development
###end article-title 93
###begin article-title 94
The Rho GTPase effector protein, mDia, inhibits the DNA binding ability of the transcription factor Pax6 and changes the pattern of neurite extension in cerebellar granule cells through its binding to Pax6
###end article-title 94
###begin article-title 95
Rosalind Franklin Centre for Genomics Research BioinformaticsApplications
###end article-title 95
###begin article-title 96
JPRED, a Consensus Method for Protein Secondary Structure Prediction
###end article-title 96
###begin article-title 97
Application of multiple sequence alignment profiles to improve protein secondary structure prediction
###end article-title 97
###begin article-title 98
###xml 4 9 <span type="species:ncbi:9606">Human</span>
The Human PAX6 Allelic Variant Database
###end article-title 98
###begin article-title 99
Psychiatric disorder and cognitive function in a family with an inherited novel mutation of the developmental control gene PAX6
###end article-title 99
###begin article-title 100
###xml 70 75 <span type="species:ncbi:9606">human</span>
Analysis of GAPDH as a standard for gene expression quantification in human placenta
###end article-title 100
###begin article-title 101
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Candidate psychiatric illness genes identified in patients with pericentric inversions of chromosome 18
###end article-title 101
###begin article-title 102
###xml 56 76 <span type="species:ncbi:59560">Phallusia mammillata</span>
Conservation of Pax-6 in a lower chordate, the ascidian Phallusia mammillata
###end article-title 102
###begin article-title 103
Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase
###end article-title 103
###begin article-title 104
Missense mutation at the C-terminus of PAX6 negatively modulates homeodomain function
###end article-title 104
###begin article-title 105
Table of False Positives
###end article-title 105
###begin article-title 106
Homer: a link between neural activity and glutamate receptor function
###end article-title 106
###begin article-title 107
The molecular motor toolbox for intracellular transport
###end article-title 107
###begin article-title 108
###xml 31 38 <span type="species:ncbi:9031">chicken</span>
The light chain composition of chicken brain myosin-Va: calmodulin, myosin-II essential light chains, and 8-kDa dynein light chain/PIN
###end article-title 108
###begin article-title 109
The tripartite motif family identifies cell compartments
###end article-title 109
###begin article-title 110
Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins
###end article-title 110
###begin article-title 111
Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins
###end article-title 111
###begin article-title 112
Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors
###end article-title 112
###begin article-title 113
The scaffold protein, Homer1b/c, regulates axon pathfinding in the central nervous system in vivo
###end article-title 113
###begin article-title 114
Identification of proteins in the postsynaptic density fraction by mass spectrometry
###end article-title 114
###begin article-title 115
Interaction of the postsynaptic density-95/guanylate kinase domain-associated protein complex with a light chain of myosin-V and dynein
###end article-title 115
###begin article-title 116
Binding of dynein light chain (PIN) to neuronal nitric oxide synthase in the absence of inhibition
###end article-title 116
###begin article-title 117
A tripartite motif protein Trim11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults
###end article-title 117
###begin article-title 118
###xml 134 137 <span type="species:ncbi:10116">rat</span>
Occurrence of a transcription factor, signal transducer and activators of transcription 3 (Stat3), in the postsynaptic density of the rat brain
###end article-title 118
###begin article-title 119
Occurrence of a transcription factor, cAMP response element-binding protein (CREB), in the post-synaptic sites of the brain
###end article-title 119
###begin article-title 120
PAX6, paired domain influences sequence recognition by the homeodomain
###end article-title 120
###begin article-title 121
Nuclear localization signals, DNA binding, and transactivation properties of quail Pax-6 (Pax-QNR) isoforms
###end article-title 121
###begin article-title 122
###xml 31 41 <span type="species:ncbi:6239">C. elegans</span>
Regulated nuclear entry of the C. elegans Pax-6 transcription factor
###end article-title 122
###begin article-title 123
Nuclear interaction of the dynein light chain LC8a with the TRPS1 transcription factor suppresses the transcriptional repression activity of TRPS1
###end article-title 123
###begin article-title 124
Screening for PAX6 gene mutations is consistent with haploinsufficiency as the main mechanism leading to various ocular defects
###end article-title 124
###begin article-title 125
###xml 113 116 <span type="species:ncbi:10116">rat</span>
The postsynaptic scaffold proteins ProSAP1/Shank2 and Homer1 are associated with glutamate receptor complexes at rat retinal synapses
###end article-title 125
###begin article-title 126
Myosin Va is required for normal photoreceptor synaptic activity
###end article-title 126

